Advanced Cancer
Advanced cancer refers to cancer that has spread from its original site to other parts of the body, making it more difficult to treat and often requiring more aggressive therapies.
Small-Cell Lung Cancer: BI 764532 Study
We are testing how well the drug BI 764532 is taken up by tumors in patients with small-cell lung cancer or neuroendocrine cancer. This study aims to understand its potential effectiveness in treating these cancers.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Large Cell Neuroendocrine Lung Carcinoma (LCNEC)
Large Cell Neuroendocrine Lung Carcinoma (LCNEC) is a rare and aggressive type of lung cancer that originates from neuroendocrine cells, often leading to symptoms like cough, chest pain, and difficulty breathing.
Neuroendocrine Carcinoma (NEC)
Neuroendocrine carcinoma (NEC) is a rare type of cancer that arises from neuroendocrine cells, which can occur in various organs, including the lungs, and may present with symptoms like abdominal pain and hormonal changes.
Small Cell Lung Carcinoma (SCLC)
Small Cell Lung Carcinoma (SCLC) is a fast-growing type of lung cancer that is strongly associated with smoking and often diagnosed at an advanced stage, leading to symptoms such as persistent cough and weight loss.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC
Afdeling Geneeskundige Oncologie
Amstelveen, Netherlands
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.